# Study of Aolanti Weikang Tablets in Healthy Volunteers

> **NCT03358485** · PHASE1 · COMPLETED · sponsor: **Jiangxi Qingfeng Pharmaceutical Co. Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Aolanti Weikang tablets
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03358485
- **Lead sponsor:** Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-14
- **Primary completion:** 2018-04-21
- **Final completion:** 2018-06-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358485, "Study of Aolanti Weikang Tablets in Healthy Volunteers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03358485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*